Home > Publications database > Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. > print

001     136830
005     20240229105101.0
024 7 _ |a 10.1038/s41467-018-04650-6
|2 doi
024 7 _ |a pmid:29915264
|2 pmid
024 7 _ |a pmc:PMC6006309
|2 pmc
024 7 _ |a altmetric:43830303
|2 altmetric
037 _ _ |a DKFZ-2018-01268
041 _ _ |a eng
082 _ _ |a 500
100 1 _ |a Wegert, Jenny
|b 0
245 _ _ |a Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.
260 _ _ |a London
|c 2018
|b Nature Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1660207982_27718
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Soft tissue tumors of infancy encompass an overlapping spectrum of diseases that pose unique diagnostic and clinical challenges. We studied genomes and transcriptomes of cryptogenic congenital mesoblastic nephroma (CMN), and extended our findings to five anatomically or histologically related soft tissue tumors: infantile fibrosarcoma (IFS), nephroblastomatosis, Wilms tumor, malignant rhabdoid tumor, and clear cell sarcoma of the kidney. A key finding is recurrent mutation of EGFR in CMN by internal tandem duplication of the kinase domain, thus delineating CMN from other childhood renal tumors. Furthermore, we identify BRAF intragenic rearrangements in CMN and IFS. Collectively these findings reveal novel diagnostic markers and therapeutic strategies and highlight a prominent role of isolated intragenic rearrangements as drivers of infant tumors.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Vokuhl, Christian
|b 1
700 1 _ |a Collord, Grace
|0 0000-0003-1924-4411
|b 2
700 1 _ |a Del Castillo Velasco-Herrera, Martin
|0 0000-0001-5956-0211
|b 3
700 1 _ |a Farndon, Sarah J
|b 4
700 1 _ |a Guzzo, Charlotte
|0 0000-0003-3742-5961
|b 5
700 1 _ |a Jorgensen, Mette
|b 6
700 1 _ |a Anderson, John
|b 7
700 1 _ |a Slater, Olga
|b 8
700 1 _ |a Duncan, Catriona
|b 9
700 1 _ |a Bausenwein, Sabrina
|b 10
700 1 _ |a Streitenberger, Heike
|b 11
700 1 _ |a Ziegler, Barbara
|b 12
700 1 _ |a Furtwängler, Rhoikos
|b 13
700 1 _ |a Graf, Norbert
|0 0000-0002-2248-323X
|b 14
700 1 _ |a Stratton, Michael R
|b 15
700 1 _ |a Campbell, Peter J
|b 16
700 1 _ |a Jones, David
|0 P:(DE-He78)551bb92841f634070997aa168d818492
|b 17
|u dkfz
700 1 _ |a Koelsche, Christian
|0 0000-0001-8763-8864
|b 18
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 19
|u dkfz
700 1 _ |a Mifsud, William
|b 20
700 1 _ |a Sebire, Neil
|b 21
700 1 _ |a Sparber-Sauer, Monika
|b 22
700 1 _ |a Koscielniak, Ewa
|b 23
700 1 _ |a Rosenwald, Andreas
|b 24
700 1 _ |a Gessler, Manfred
|0 0000-0002-7915-6045
|b 25
700 1 _ |a Behjati, Sam
|b 26
773 _ _ |a 10.1038/s41467-018-04650-6
|g Vol. 9, no. 1, p. 2378
|0 PERI:(DE-600)2553671-0
|n 1
|p 2378
|t Nature Communications
|v 9
|y 2018
|x 2041-1723
909 C O |p VDB
|o oai:inrepo02.dkfz.de:136830
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)551bb92841f634070997aa168d818492
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 0000-0001-8763-8864
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Functional and structural genomics
|x 0
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NAT COMMUN : 2015
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 1
920 1 _ |0 I:(DE-He78)B300-20160331
|k B300
|l KKE Neuropathologie
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a I:(DE-He78)B300-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21